Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
- 1 January 1982
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 35 (8) , 1049-1054
- https://doi.org/10.7164/antibiotics.35.1049
Abstract
The antitumor activities of forphenicinol against murine transplantable tumors were examined. Ehrlich carcinoma was suppressed by treatment with 0.08-0.31 mg/kg per day of forphenicinol given for 10 days starting 5 days after tumor inoculation. IMC carcinoma was also suppressed by treatment with 0.5-5 mg/kg per day given for 5 days starting 8 days after the inoculation. The antitumor activity was dependent on the number of tumor cells inoculated, schedule of administration and dose. Even in the case of fast growing tumors such as L 1210 and inoculation with a large number of tumor cells, forphenicinol markedly enhanced the antitumor effect of 6-mercaptopurine, aclacinomycin and cyclophosphamide. Forphenicinol showed a protective effect on Pseudomonas infection in mice.This publication has 4 references indexed in Scilit:
- Studies on effects of forphenicinol on immune responses.The Journal of Antibiotics, 1982
- On the mechanism of tumor ‘concomitant immunity’International Journal of Cancer, 1981
- Effect of bestatin on mouse immune system and experimental murine tumors.The Journal of Antibiotics, 1980
- KILLING OF TUMOR-CELLS INVITRO BY MACROPHAGES FROM MICE TREATED WITH SYNTHETIC DEHYDRODIPEPTIDES1979